Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse

Gastroenterology

Volumn 103, Issue 2, 1992, Pages 617-621

  Calmus, Yvon ^a,b   Weill, Bernard ^a,b   Ozier, Yves ^a,b   Chéreau, Christiane ^a,b   Houssin, Didier ^a,b   Poupon, Raoul ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CYCLOSPORIN; CYTOKINE; URSODEOXYCHOLIC ACID;

ANIMAL CELL; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; CELL VIABILITY; CELLULAR IMMUNITY; CHOLESTASIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMAL; CELL DEATH; CELLS, CULTURED; CHENODEOXYCHOLIC ACID; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; SUPPORT, NON-U.S. GOV'T; URSODEOXYCHOLIC ACID;

EID: 0026663426     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(92)90855-S     Document Type: Article

References (31)

1. Effect of biliary obstruction on skin allograft survival in mice
2. Profound suppression of lymphocyte function in early biliary obstruction
3. Anergy in jaundiced patients
4. Depression of lymphocyte reactivity to phytohemagglutinin by serum from patients with liver disease
5. Immune status in mice with experimental biliary obstruction
6. Enhancement of heterotopic cardiac allograft survival by experimental biliary ligation
7. Suppression of host-versus-graft response in experimental biliary obstruction
8. Surgical experience of deeply jaundiced patients with bile duct obstruction
9. Perioperative complications in obstructive jaundice: therapeutic considerations
10. Bile acid-induced inhibition of the proliferative response to phytohemagglutinin and pokeweed mitogen: An in vitro study
11. Impairment of human lymphocyte functions by bile salts
12. Disturbances of bile acid metabolism in cholestasis
13. Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem
14. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
15. A multicenter double blind trial of ursodiol for the treatment of primary biliary cirrhosis
16. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment
17. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid
18. Composition of several mammalian biles and their membrane-damaging properties
19. Tissue-bound bile acids
20. Therapeutic response and toxicity
21. The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat
22. Changes in production of interleukin-1 and interleukin-2 associated with obstructive jaundice and biliary drainage in patients with gastrointestinal cancer
23. Production of Tumor necrosis Factor, Interleukin-1, by peripheral blood mononuclear cells from patients with primary biliary cirrhosis
24. Role of intracellular calcium concentration and protein kinase C activation in IFN-γ stimulation of U937 cells
25. The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids
26. Hepatotoxic bile acids increase cytosolic Ca++ activity of isolated rat hepatocytes
27. Pathogenesis of primary biliary cirrhosis. New aspects of the role of T lymphocytes
28. Lack of cytokine mRNA expression in the liver of patients with primary biliary cirrhosis
29. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss
30. A controlled trial of cyclosporin in the treatment of primary biliary cirrhosis
31. Cyclosporine A in primary biliary cirrhosis: results of a long-term placebo controlled trial and effect on survival (abstr)